We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

Reports record full-year revenue and profit, and proposes a 20% dividend increase SCHAFFHAUSEN, Switzerland, Feb. 19, 2025 /PRNewswire/ -- Garmin® Ltd. (NYSE: GRMN) ...

Reports FY24 revenue $65.85B vs. $64.91B last year. Constant currency revenue excluding notable items rose by $2.9B to $67.4B. Profit before ...

Reports Q4 revenue $326.6M, consensus $325.22M. “Steady, reliable, and consistent, are some of the words used to describe what was an ...

Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...